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open access article under the CC BY-NAbstract Introduction: Central to all efforts to control and prevent healthcare associated in-
fections (HAIs) is the inherent need to measure the burden of infection and disease, classically
referred to as surveillance. Australia does not have a national HAI surveillance system making
it very difficult to systematically assess and report on the burden of hospital-acquired HAIs.
This systematic review reports the incidence burden of HAIs in Australian hospitals as reported
in the peer-reviewed literature from 2010 to 2016.
Methods: Systematic review of the peer-reviewed literature reporting the incidence of HAIs in
Australian hospitals between from 2010 to 2016 was identified using MEDLINE and CINAHL da-
tabases. The study protocol is registered with PROSPERO (registration number:
CRD42016052997).
Results: Of the 844 articles identified in the search, 24 articles were included in this review.
Overall, these data suggest 83,096 HAIs per year in Australia, comprising 71,186 urinary tract
infections, 4902 Clostridium difficile infections, 3946 surgical site infections, 1962 respiratory
infections in acute stroke patients and 1100 hospital-onset Staphylococcus aureus bacterae-
mia. This is very large underestimate given the lack of or incomplete data on common infec-
tions such as pneumonia, gastroenterological and bloodstream infection, thus potentially
missing up to 50%e60% of infections. If that is the case, the incidence of HAIs in Australia
may be closer to 165,000 per year.
Conclusion: There is a dearth of peer-reviewed literature reporting the incidence of HAIs in
Australian hospitals, making it very difficult to an accurate burden of infection. On the evellege, Clinical Education Centre, 185 Fox Valley Road, Wahroonga, NSW, 2076, Australia.
ondale.edu.au (B.G. Mitchell).
.07.001
hed by Elsevier B.V. on behalf of Australasian College for Infection Prevention and Control. This is an
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
118 B.G. Mitchell et al.of a global ‘post antibiotic era’, the need for national consensus on definitions, surveillance
methodology and reporting is paramount.
ª 2017 The Authors. Published by Elsevier B.V. on behalf of Australasian College for Infection
Prevention and Control. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Highlights
 This systematic review reports on the incidence burden of HAIs in Australian hospitals.
 There are approximately 165,000 HAIs occurring each year in Australia.
 There is a need for improved surveillance and reporting of HAIs in Australia.Introduction
Healthcare-associated infections (HAIs) are a major patient
safety issue in hospitals. While research into infection
prevention and control has led to improvements in our
understanding of effective HAI prevention strategies [1],
HAIs continue to occur and lead to morbidity, mortality and
excess healthcare expenditure [1,2]. Unlike most devel-
oped countries, Australia does not have a national system
to monitor these infections and cannot provide an estimate
of the burden of hospital-acquired HAIs. The last national
point prevalence study conducted in Australia occurred in
1984 [3]. Healthcare delivery, technology and infection
prevention and control initiatives have advanced consid-
erably since this time.
In 2008, Cruickshank and Ferguson [4] estimated that
there are about 200,000 HAIs each year in Australia, which
if correct makes them the most common complication
affecting patients in hospital. There has not been a sub-
sequent evidence-based estimate of the incidence of HAIs
in Australia despite HAIs being widely reported as the most
common complication affecting patients in hospital glob-
ally. The purpose of this systematic review was to explore
the burden of HAIs in Australian hospitals by determining
the incidence of HAIs in Australian hospitals, as reported in
the peer-reviewed literature from 2010 to 2016.
Methods
Protocol and registration
The protocol for this review is registered with PROSPERO,
an international prospective register of systematic reviews
(available at http://www.crd.york.ac.uk/prospero/ with
registration number: CRD42016052997). Ethics approval
was not sought because this review used data from
published studies.
Search strategy
A systematic search was conducted using the electronic
databases MEDLINE (PubMed) and the Cumulative Index to
Nursing and Allied Health Literature (CINAHL) to search for
articles published between 1 January 2010 and 31
December 2016. The timeframe was chosen to include themost current HAI data. During the 2000s, a number of state
and national initiatives were undertaken to reduce HAIs,
including the national hand hygiene initiative, development
of National Health and Medical Research Council guidelines,
revision of hospital accreditation standards, surveillance
initiatives and public reporting of some infection data
[5e7]. Reference lists of eligible articles relating to these
initiatives were reviewed to identify any additional
articles.
To identify articles from MEDLINE and CINAHL, the
search terms “surveillance”, “incidence”, “prevalence”,
“frequency”, “rates or statistics” and “performance in-
dicators” were used in combination with “nosocomial
infection”, “hospital acquired infection”, “healthcare
associated infection”, “cross infection” and “infection”. To
identify and limit the search to articles from Australian
hospitals, the search term “hospital” was used with
“Australia”, “Australian”, “Queensland”, “New South
Wales”, “Australian Capital Territory”, “Victoria”, “Tas-
mania”, “South Australia”, “Western Australia” and
“Northern Territory”. These terms were applied using an all
text search. For the MEDLINE search, the MeSH terms
“epidemiology”, “cross Infection” and “disease trans-
mission, infectious” were also used.
Inclusion criteria
Articles were eligible if they reported the results of cohort
studies, case-control studies, cross-sectional studies,
randomised controlled trials or case reports (reporting
incidence) of HAI. For this study, cohort studies include
studies where a population is followed up to determine
whether they subsequently acquire an infection. To be
eligible, data collection had to occur after 1 January 2010.
Articles were limited to studies conducted in Australian
hospitals. For international or multi-centre studies, data
from Australian hospitals was included if the data was re-
ported at this level. Where Australia-specific data was not
available, the study was excluded.
Exclusion criteria
The following exclusion criteria applied: all grey literature,
non-peer reviewed, conference abstracts, papers written in
languages other than English, reviews, editorials, com-
mentaries or policy statements.
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For this review, the definition of HAI used in the articles
must have referenced a recognised standard such as a
definition agreed or published by professional association or
government agency, a definition widely used in the pub-
lished literature or an ICD10 code that constitutes a HAI
(not any infection). Any disputes about whether an article
had used an appropriate definition were resolved by dis-
cussion among the reviewers.Study selection
The titles and abstracts of the articles identified from MED-
LINE and CINAHL were examined and assessed for relevance
and appropriateness to the review question by one reviewer
(CW). Those not relevant were excluded. For a random se-
lection (10%) of articles, the abstracts were independently
reviewed by another reviewer (BM) to identify any discrep-
ancies; none were identified. Of the remaining articles, a full
text review was undertaken (CW) to assess eligibility. Where
there was uncertainty as to whether an article should be
included, two researchers independently reviewed the arti-
cles (PR and RS). If there was disagreement, a third reviewer
made the final determination (BM).Data collection process
A data extraction form was developed for extracting data
for the systematic review (Supplementary 1). All data items
extracted were cross-checked. No attempt was made to
contact the authors of papers that had missing data or
unclear information.Risk of bias
An assessment of study quality and risk of bias in the articles
included in the review was conducted using the New-
castleeOttawa Scale, as recommended by the Cochrane
Collaboration [8,9]. The tool enables amaximumof nine stars
to be awarded to a study. The content validity and inter-rater
reliability of this tool has been established [9]. Two reviewers
undertook this assessment independently (PRandRS). Forany
discrepancies, a third reviewer (BM) made the final determi-
nation. We were unable to determine level of bias associated
with not including all HAIs in the review. Publications on the
HAI incidence (or prevalence) varies considerably and in-
cludes the possibility of not publishing any data, not reporting
on all HAIs a lack of sensitivity in HAI surveillance or meth-
odological approaches used and a lack of validation. Such an
issue is not limited to this study and is widespread in the area
of HAI data, particularly in Australia [10e12].Data analysis
All extracted data was entered into a comprehensive
evidence-base table for descriptive analysis; 95% confi-
dence intervals were calculated using Poisson regression.
Meta-analysis was not performed due to the studies’heterogeneous methods, in particular, data collection.
Meta-regression was not possible for the same reason.
Estimating the annual incidence of HAIs in Australia
We estimated the annual incidence of HAIs in Australia by
extrapolating and modelling data from multi-centre studies
that observed the same type of infection. Only multi-centre
studies were used in the estimation, as they are likely to be
more representative than single site studies. To estimate
the annual number of cases of hospital onset Staphylo-
coccus aureus bacteraemia and hospital identified Clos-
tridium difficile, the total number of cases of each
infection (identified in the included studies) was divided
was divided by population data and subsequently multiplied
by the Australian population. Population data was aggre-
gate population of the states and territories contributing to
the data. Population data for states territories and
Australia was obtained from the Australian Bureau of Sta-
tistics, with 2016 population estimates used [13].
To calculate the estimated number of cases of respira-
tory infections and surgical site infections, the raw data
from studies was recalculated (if not reported) to determine
the incidence (number of cases/number of procedures
surveyed  100). Confidence intervals were also calculated.
Where studies contained incidence data for more than one
year, the data from the last reported year in the study was
used for modelling to ensure the most recent data was used.
If incidence data was not reported by year, the incidence for
the entire study period was used for modelling.
Data from the Australian Institute of Health and Welfare
and the Australian Commission on Safety and Quality was
used to determine the number of procedures performed
each year in Australia [14e17]. The calculated incidence
was multiplied by the number of reported procedures per
year, to give an estimated number of cases per year in
Australia.
The number of healthcare associated urinary tract in-
fections was reported as an incidence per 100 patient ad-
missions in the literature. To determine the number of
patient admissions per year in Australia, separation data
from the Australian Institute of Health and Welfare was
used [16]. Overnight separations are the closest available
denominator to patient admissions. The reported incidence
in the literature was multiplied by the number of overnight
separations, to provide an estimated number of cases per
year in Australia.
Results
Study selection
The initial database search identified 843 articles, with one
additional article identified through hand searching. After
duplicate articles were removed, 751 abstracts were
reviewed and 105 articles were deemed suitable for a full
text review. Twenty-four studies met the eligibility criteria
and were included in this review. The Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
flow chart describing the papers identified from the search
strategy is presented in Fig. 1.
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Figure 1 PRIMSA flow diagram for study selection.
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When studies were assessed for risk of bias using the
NewcastleeOttawa scale, the number of stars awarded to
studies ranged from five to eight, the median being seven.
Study characteristics
A summary of the included articles with an overview of
their key characteristics is provided in Table 1. Of the 24
included articles, the most common infections surveyed
were bloodstream infections (eight articles), surgical site or
procedure infections (six articles) and respiratory in-
fections (four articles). C. difficile infection was reported
in three articles, with the remainder reporting multiple or
other infections. There was variation in the methodological
approaches used to identify infections, the definitions used
to determine an infection, the patients included in the
studies and the number of hospitals involved. Four of the
articles involved hospitals in more than one state. Eight
articles involved hospitals from Victoria only, making this
state the most represented.Results by type of infection
Bloodstream infection
Four of the eight articles reported bloodstream infections
at a hospital level; the remainder examined either blood-
stream infections within an intensive care unit or patients
who were undergoing a procedure. There was further
variation in the types of bloodstream infections surveyed,
with S. aureus bacteraemia the most common. There was
some consistency in the methods used to determine the
incidence of S. aureus bacteraemia. The reported inci-
dence of hospital-acquired S. aureus bacteraemia was 0.77
per 10,000 bed days from New South Wales hospitals and
1.33 per 10,000 bed days from Queensland hospitals [18].
Mitchell et al. reported an incidence of 0.90 per 10,000 bed
days for hospital-onset S. aureus bacteraemia [19], but did
not include hospitals from New South Wales, Queensland or
Victoria. In this study by Mitchell et al. [19], hospital-
acquired S. aureus bacteraemia was defined as a S.
aureus bacteraemia occurring more than 48 h after
admission, whereas the article based on New South Wales
and Queensland data used these criteria in addition to
Table 1 Overview of study findings.
Lead author Location
(no hospitals)
Hospital
type
Data
collection
Infection type Population Process Key results Definitions
Bloodstream infections
Alcorn [20] QLD (1) Principal
referral
2001e2011 Bloodstream
infection (BSI)
All hospital Retrospective All: 841/10,000 overnight discharges
Gram negative: 7.8/10,000
Gram positive: 12.6/10,000
AUS
Anderson [21] NSW (1) Private 2009e2013
(5 years)
Bacteraemia
following TRUS
biopsy.
One surgeon’s
patients
ICD, data
warehouse & chart
review.
1.5% (71 patients) bacteraemia over 5
years.
EST
Aubron [22] VIC (1) Principal
referral
2006e2011
(6 year)
BSI associated
with positive ICU-
acquired positive
urine culture
ICU Retrospective Candiduria 3.5 episodes/1000 ICU day
Bacteriuria 2.8 episodes/1000 ICU day
COM
Coombs [24] All (29) Various 2011 S. aureus
bacteraemia
All hospital, only
first 100 collected
Laboratory based.
Period prevalence.
MRSA accounted for 30.3%, 2357
isolates.
COM
Mitchell [19] WA, SA, TAS,
ACT (132)
Various S. aureus
bacteraemia1
All hospital Prospective 0.90/10,000 patient days (95% Cl
0.86e0.93)
COM
Mumford [41] NSW (77) Various 2009e12 S. aureus
bacteraemia2
All hospital Retrospective Peer group A Z 1.52 per 10,000 bed
days
Peer group B Z 0.93 per 10,000 bed
days
Peer group C Z 1.06 per 10,000 bed
days
Peer group D Z 0.62 per 10,000 bed
days
All (2012)Z 0.77 per 10,000 bed days
AUS
Si [18] QLD (23) Various 2008e12 S. aureus
bacteraemia1,2
All hospital Prospective Inpatient BSI 6.0/10,000 patient days
Inpatient, intravascular associated:
1.9/10,000 patient days
Inpatient, S. aureus bacteraemia 1.0/
10,000 patient days
HCA S. aureus bacteraemia
1.3/000 patient daysa
AUS
Wong [23] VIC (1) Principal
referral
2008e2014
(5 years, 10m)
ICU-acquired
central line-
associated
bloodstream
infection (CLABSI)
ICU Retrospective ICU-acquired CLABSI 1.1 per 1000 ICU
CVC-days
INT
Surgical site/procedure related
Chandrananth
[25]
VIC (3) Unknown 2011e2014
(3 year)
Surgical site
infection
Hip or knee
arthroplasty.
Retrospective 2.7% infection rate INT
(continued on next page)
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Table 1 (continued )
Lead author Location
(no hospitals)
Hospital
type
Data
collection
Infection type Population Process Key results Definitions
Phan [42] ACT (1) Principal
referral
2007e2010 External
ventricular drains
infection
Patient with
external
ventricular drains
Retrospective 13 infections from 114 patients
(11.5%)
CLIN
Roth [28] VIC (311) Various 2007e2012 Infective
complication
following TRUS
biopsy
Patients post TRUS
biopsy
Victorian
Admitted Episodes
Data Set
1.73%, 95% (Cl 1.63e1.92%)
readmitted with infection (604 of
34,865 patients).
CLIN
Tao [26] VIC (1) Principal
referral
2012 (1 month) Surgical site
infection
Orthopaedic
patients
Retrospective 7% surgical site infection. 95
procedures (6 superficial. 1 deep)b
INT
Worth [27] VIC (81) Various 2002e15 Surgical site
infection
All hospital Prospective 2.8 per 100 procedures surgical site
infection. (95% CI 2.7e2.9). 5123
infections from 183,625 procedures.
- 53.5% super-ficial
- 23.6% deep incisional
- 22.9% organ/space infections
Coronary artery bypass
surgery Z 4.9/100 procedures
(1137/23,108)
Caesarean section Z 2.0/100 pro-
cedures (1044/50,833)
Hip/knee Z 2.6/1000 procedures
(1453/56,503)
Colorectal Z 8.6/100 procedures
(753/8688)
Other abdominal Z 2.6/100 pro-
cedures (290/10,993)
Cardiac non coronary artery bypass
surgery Z 3.8/100 procedures
(133/3458)
Hysterectomy Z 2.0/100 proced-
ures (131/6504)
Vascular Z 11.8/100 procedures
(48/407)
INT
Ezzatzadegan
[43]
NSW (1) Principal
referral
2000e2010
(10 years)
Invasive fungal
infection
Renal transplant
recipients
Retrospective 2.1%, 95% (CI 0.7%e3.4%)
(10/471 patients)
CLIN
Respiratory
Brogan [29] NSW (6) Principal
referral
2010 Respiratory
infections in acute
stroke.
Stroke patients Retrospective 11.3 % (60/(533 patients)) NS
Gautam [44] NSW (1) Principal
referral
(1 year) Ventilator-
associated
paediatric
intensive care
Prospective
observational
7.02/1000 ventilation days
(18 episodes/269 patients)
INT
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pneumonia unit:
Macesic [30] All (15) Various 2010e11 Hospital-acquired
influenza
All hospital Sentinel 4.3% of cases were nosocomial. (26/
598 cases)
CLIN
Sanagou [31] NS (16) Various 2001e2011 HCA pneumonia
post cardiac
surgery.
Retrospective
(registry)
5.1% (2229 cases/43,691 patients)
C. difficile
Foster [32] WA (2) Principal
referral
2011e12
(6 months)
C. difficile
infection
All hospital Retrospective Hospital 1 Z 6.8 cases/10,000 OBDs
Hospital 2 Z 8.0 cases/10,000 OBDs.
53.8% of cases were hospital-onset.c
AUS/INT
Slimings [33] TAS, VIC,
NSW, QLD,
SA, WA,
ACT (450)
Various 2011e12 C. difficile
infection
All hospital Prospective Hospital identified: 3.65 (95% CI 3.58
e3.71) per 10,000 patient days
(12,683 cases/34786323 patient day)
Hospital associated 2.95 (95% CI 2.86
e3.04) per 10,000 patient days (WA,
SA, ACT,TAS, VIC only. 6759 cases/
5,585,533 patient days)
AUS
Worth (2016)
[34]
VIC (136) Various 2010e2014 C. difficile
infection
All hospital Prospective Healthcare associated 2.49 cases per
10,000 occupied bed days. (4826
cases)
INT
All other
Jarratt SA (1) Private
hospital
2003e2011
(9 years)
HCA infections
(various)
All hospital (>18
years)
Retrospective 1017 HAIs
w0.63% of all patients admitted to
the hospital
CON
Mathot [45] VIC (1) Children 2002e12
(11 years)
Bacteraemia and
pneumonia
Paediatric ICU Prospective 8.9% patients had serious bacterial
infections (blood culture or bronchial
alveolar lavage) (881 of 9947
patients)
CLIN
Mitchell [35] NSW (8) Various Urinary tract
infection1
All hospital Retrospective 1.73% (96% CI 1.67e1.80) of admitted
patients. (2821/162,503 patient
admissions)
EST
Note: HCAZ healthcare associated. BSIZ bloodstream infection. ICUZ intensive care unit. TRUSZ transrectal ultrasound. ICDZ International Statistical Classification of Diseases and
Related Health Problems. WA Z Western Australia. SA Z South Australia. ACT Z Australian Capital Territory. TAS Z Tasmania. NSW Z New South Wales. QLD Z Queensland.
MRSA Z Methicillin resistant S. aureus AUS Z Consistent with Australian or nationally used/agreed definition. INT Z Consistent with national Healthcare Safety Network (NHSN) and or
Centres for Disease Control definitions. EST Z consistent with an established or previously documented definition (for example, professional association). NS Z Not stated.
COMZ Common approach to defining a healthcare associated infection e consistent with not incubating on admission and or acquired 48 h after admission. CLINZ defined as an infection
based on clinical grounds, assessment or review of notes. 1Hospital onset. 2Healthcare associated.
a Calculated from available data.
b Unadjusted rate/not risk adjusted.
c Unable to determine combined incidence from available data.
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124 B.G. Mitchell et al.other criteria. The combined incidence of hospital-
acquired S. aureus bacteraemia was 0.93 cases per 10,000
bed days (95% CI 0.90e0.96) [18,19]. Other articles
reporting bloodstream infection rates were limited to one
hospital [20e23] or did not report the incidence of blood-
stream infection [24].
Surgical site or procedure related infection
Three studies reported the incidence of surgical site
infection in orthopaedic patients [25e27], but only two of
these reported rates at a procedure level [25,27]. Both of
these studies included hospitals from Victoria and had
overlapping study periods. In addition to these studies,
Roth et al. [28] undertook a multi-centre study to deter-
mine the incidence of infectious complications following
trans-rectal ultrasound. This study examined data from
31,209 patients from public and private hospitals over a
five-year period and found that 1.73% of these patients
were readmitted with a biopsy-related infection [28].
Respiratory
The articles that reported respiratory HAI were heteroge-
neous in terms of the type of infections, the participants
monitored and the methodological approaches used. Three
were multi-centre studies but reported on different HAI:
respiratory infections in acute stroke patients [29], influ-
enza [30] and pneumonia following cardiac surgery [31].
C. difficile infection
Three multi-centre studies examined C. difficile infection
with overlapping data collection periods [32e34]. The study
by Slimings et al. [33] was conducted in seven Australian
states and territories and involved 450 public hospitals. The
incidence of hospital-identifiedC. difficile infectionwas 3.65
per 10,000 bed days, while the incidence of hospital-
associated C. difficile infection was 2.95 per 10,000 bed
days (from five states and territories). This finding is consis-
tent with that of Worth et al. [34], who examined C. difficile
infection in 136 healthcare facilities over a four-year period
and found the incidence of healthcare-associated C. difficile
infection to be 2.49 cases per 10,000 bed days. From the
published data, wewere unable to calculate the incidence of
healthcare-associated C. difficile infection in the study un-
dertaken in Western Australia [32].
Other
Three studies examined other HAI but only one study was
multi-centre [35]. In this study examining the incidence of
healthcare-associated urinary tract infections in eight hos-
pitals over a four-year period, the authors found that 1.7% of
admitted patients acquired a HAI of the urinary tract.
Estimates of yearly HAI incidence
Using data from multi-centre studies, we sought to esti-
mate the number of HAI occurring each year in Australia
(Table 2). From the available data, we estimate 83,096 HAIs
occur each year in Australia, however this number is a
significant underestimation, it was only based on peer-
reviewed published multi-centre studies Included in our
review. The 83,086 HAIs comprised of 71,186 urinary tractinfections, 4902 healthcare associated C. difficile in-
fections, 3946 surgical site infections, 1962 respiratory in-
fections in acute stroke patients and 1100 hospital onset S.
aureus bacteraemia infections.Discussion
This paper presents the first systematic review of Australian
HAI rates published in the peer-reviewed literature. We
identified 24 studies published between 2010 and 2016. The
infections surveyed, their definitions and the methods used
varied considerably. To understand the magnitude of HAIs
and associated burden of disease in Australia more fully, we
attempted to estimate the incidence of HAIs using data
from multi-centre studies.
A previous report estimated the incidence of HAIs in
Australia to be 177,392 HAIs per year (headline number of
200,000 HAIs) [4]. This estimate was made several years ago
and was based on one study conducted in one hospital; the
best available data at that time. Unfortunately, the evi-
dence base for estimating the incidence of HAIs in Australia
remains lacking, certainly when using data from the peer-
reviewed literature. Our review has highlighted a myriad
of different approaches to measure and define HAIs. In
many instances, the data presented was limited, making
comparisons or extrapolation of data impossible. In the
absence of a national system for reporting there is a real
need for those undertaking HAI surveillance e both at a
hospital and a state level e to publish HAI surveillance data
in the peer-reviewed literature. Accessing such information
from government websites is fraught with challenges,
including lack of detail about methods, delays in publishing
data or failure to publish data. These issues do not apply to
all states and territory health departments, but there are
significant gaps across the country. This was also reflected
in the results of our literature review, where more articles
were published from Victorian data than any other state.
Limited data is available from other states or on the
MyHospitals website (www.myhospitals.gov.au).
National point prevalence studies are undertaken peri-
odically in numerous countries including the United States,
Canada and all European countries [2,36,37]. Australia is
one of the few Organisation for Economic Co-operation and
Development countries that does not undertake national
HAI point prevalence studies, or have a national surveil-
lance program [10]. These studies provide valuable insights
into the most frequent HAIs: gastroenterological, respira-
tory, surgical site and urinary tract. Our review has iden-
tified few studies that explored the incidence of
gastroenterological and respiratory infections, despite
these being the most common. Surgical site infection data
was well represented from studies from Victoria and urinary
tract infection from New South Wales [26e28,35]. The data
included in our review misses a large proportion of HAIs due
to the absence of published incidence data.
Using data from the multi-centre studies to improve
representativeness, we estimated the incidence of some
types of HAIs. We estimate that each year in Australia,
there are 71,186 urinary tract infections, 4902 C. difficile
infections, 3946 surgical site infections, 1962 respiratory
Table 2 Multi-centre studies and estimates of healthcare-associated infections in Australia.
Infection Lead author Data extracted or recalculated from studies for model Estimated denominator.- Modelled number of
cases in Australia each
year
Bloodstream infection
Hospital onset S. aureus
bacteraemia
Mitchell [19] 253 cases in WA, SA, ACT, TAS in 2012. 5.24 million population 1100 cases per year (95%
CI 995e1193)
Si [18] 207 cases from QLD in 2012. 4.84 million population.
Healthcare associated
S.aureus bacteraemia
Mumford [41] 0.77 (SD 0.77) Unable to modela
Subtotal 1100
Surgical site infection
Hip and knee Worth [27] 2.57/100 procedures (95% CI 2.44e2.71) 25,938 procedures/year. Hip/knee Z 667 casesb,c
(Public hospitals)
Chandrananth [25] 2.75/100 procedures (95% CI 1.86e3.9)^
Coronary artery bypass
surgery
Worth [27] 4.51/100 procedures (95% CI 2.72e7.05) 3837 procedures/year. 189 casesc (Public
hospitals)
Caesarian section Worth [27] 2.75 (95% CI 2.26e3.32) 95,894 procedures/year. 1969 casesc (All
hospitals)
Hysterectomy Worth [27] 2.01 (95% CI 1.68e2.39) 9989 procedures/year. 201 casesc (Public
hospitals)
Vascular Worth [27] 11.79 (8.70e15.64) 4002 procedures/year. 472 casesc.d (Public
hospitals)
Infective complication
following TRUS biopsy
Roth [28] 1.73%, (95% Cl 1.63e1.92%) readmitted with infection 25,869 procedures/year. 448 cases (All hospitals)
Subtotal 3946
Respiratory
Respiratory infections in
acute stroke
Brogan [29] 11.3% (95% CI 8.7e14.4%) of patients 15,684 cases on hospital per year 1766 casese (All
hospitals)
Influenza Macesic [30] 4.5% (95% CI 2.9e6.3%)^ Unable to modela
Pneumonia post cardiac
surgery.
Sanagou [31] 5.1% (95% CI 4.9e5.3%)^ 3837 procedures/year. 196 cases (Public
hospital)
Subtotal 1962
Other
C. difficile infection
(healthcare
associated)
Slimings [33] 2.95 (95% CI 2.86e3.04) per 10,000 patient days. 2298 cases
from WA, SA, AC, VIC and TAS.#
11.3m population. 4902 cases per yearf
C. difficile infection
(healthcare
associated)
Worth [34] 2.49 cases per 10,000 OBDs þ
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126 B.G. Mitchell et al.infections in acute stroke patients and 1100 S. aureus
bacteraemia. These total 83,096 HAIs each year, but would
be a very large underestimation given the lack of data on
common infections. These estimates also come with
considerable caveats due to the different methodologies
and definitions. In the only national data available, our
estimates for S. aureus bacteraemia are broadly consistent
with that reported by the Australian Institute of Health and
Welfare, who report 1440 cases of healthcare associated S.
aureus bacteraemia in the 2015e16 financial year [38]. The
difference is likely explained by case definitions (hospital
onset Vs healthcare associated).
Data from the United States and Europe suggests that
pneumonia accounts for 21.8%e25.7% of HAIs: 7.8%e17.1%
are gastroenterological infections, 9.9%e14.2% are blood-
stream infections, and 3.1%e5.6% are ear, nose and throat
infections [2,36]. Our review only had data on the incidence
of pneumonia from one group of patients (post-stroke) and
one bloodstream infection (S. aureus bacteraemia). C.
difficile infection was the only gastroenterological infec-
tion included in our review and we had no data on ear, nose
or throat infections or many other HAIs such as central
nervous system, reproductive tract and skin and soft tissue
infections. Therefore, our estimate of 83,096 infections
does not take into account a large proportion of pneu-
monia, gastroenterological, bloodstream infection or other
infection data, thus potentially missing up to 50%e60% of
infections. If that is the case, the incidence of HAIs in
Australia may be closer to 165,000 per year.
One limitation of our review was that we did not source
grey literature, specifically HAI data published on state and
territory government websites. These data are difficult to
locate, are reported differently and often used methodol-
ogy that is not adequately described in an open forum. We
recommend a follow-up review, focussing on collating and
analysing this data. This approach was outside the scope of
our review and available resources, and should be under-
take in a future review.
Having a reliable estimate for the incidence of HAIs is
important for a number of reasons. First, in an era of finite
health resources, it helps prioritise infection prevention
and control strategies. Second, it provides a benchmark
against which future achievements or targets can be
measured and evaluated. Third, it enables industry and
those involved in healthcare innovation to have more reli-
able data for investment in products and research. Finally,
it helps determine the resources required for HAI preven-
tion and control relative to other health issues. On the eve
of a global ‘post-antibiotic era’ [39], the need for coordi-
nated and systematic national surveillance and reporting of
HAIs and established contributing factors, namely antimi-
crobial resistance and antibiotic usage, has never been
greater.
We believe three concurrent strategies are required to
address this gap. There needs to be a determination and
action by state and national government bodies to achieve
consensus on definitions, approaches to surveillance and
transparent regular reporting. This should happen in par-
allel to the establishment of a national HAI surveillance
program. There have been calls for a national centre for
disease control [40], potentially a national HAI surveillance
program could be incorporated into such a centre. Finally, a
Burden HAIs in Australia 127national point prevalence study would provide valuable
insight in the short term on the burden of HAIs in Australia.
Given that the latter does not require a sophisticated study
design and provides descriptive results, it has not been
favourably supported by funding bodies. Whilst these sug-
gested strategies have to date failed to eventuate, we call
on all those involved in undertaking HAI surveillance in
Australia to work collaboratively and publish data in the
peer-reviewed literature.Authorship statement
BM and PR conceived the study and drafted the research
protocol. BM, PR, RS and DM provided critical review of and
approved the study design. BM conducted the database
searches. CW made the primary selection of eligible papers
including data extraction. BM, PR and RS supervised and
checked the study selection process and data extraction. BM
analysed the data. All authors contributed to interpretation
of the analysis. BM and CWwrote themanuscript. All authors
provided critical review and approved the final manuscript.Conflicts of interest
BM, PR and DM were authors on some of the included papers
in this review. The decision to include/exclude studies
which they authored, in addition to a risk of bias assess-
ment was made independently by other members of the
research team. All data extracted from these studies were
independently checked by other members of the research
team. The authors have no other conflicts to declare.Funding
Funding to support this study was provided by Avondale
College of Higher Education, via a summer scholarship
grant.Provenance and peer review
Not commissioned; externally peer reviewed.
Appendix A. Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.idh.2017.07.001.References
[1] Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP,
Dubberke ER, Ellingson KD, et al. A compendium of strategies
to prevent healthcare-associated infections in Acute Care
Hospitals: 2014 updates. Am J Infect Control 2014;42(8):
820e8.
[2] Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G,
Kainer MA, et al. Multistate point-prevalence survey of health
careeassociated infections. N Engl J Med 2014;370(13):
1198e208.[3] McLaws M, Gold J, King K, Irwig L, Berry G. The prevalence of
nosocomial and community-acquired infections in Australian
hospitals. Med J Aust 1987;149(11e12):582e90.
[4] Cruickshank M, Ferguson J, editors. Reducing harm to patients
from healthcare associated infections: an Australian infection
prevention and control model for acute hospitals. Sydney:
Australian Commission on Safety and Quality in Health Care;
2009.
[5] Graves N, Page K, Martin E, Brain D, Hall L, Campbell M, et al.
Cost-effectiveness of a national initiative to improve hand
hygiene compliance using the outcome of healthcare associ-
ated Staphylococcus aureus bacteraemia. PLoS One 2016;
11(2):e0148190.
[6] Australian Commission on Safety and Quality in Health Care.
National safety and quality health service standards. Sydney:
Australian Commission on Safety and Quality in Health Care;
2011.
[7] National Health and Medical Research Council. Australian
guidelines for the prevention and control of infection in
healthcare (2010). Canberra: National Health and Medical
Research Council; 2010.
[8] Higgins J, Green S. Cochrane handbook for systematic reviews
of interventions. Cochrane Collaboration; 2011 [updated
March 2011], Version 5.1.0.
[9] Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M,
et al. The Newcastle-Ottawa Scale (NOS) for assessing the
quality of nonrandomised studies in meta-analyses. Ottawa
Hospital Research Institute; 2014.
[10] Russo PL, Cheng AC, Mitchell BG, Hall L. Health-
care-associated infections in Australia: tackling the known
unknowns. Aust Health Rev 2017 Mar 7. http://dx.doi.org/
10.1071/AH16223 [Epub ahead of print].
[11] Russo PL, Barnett AG, Cheng AC, Richards M, Graves N, Hall L.
Differences in identifying healthcare associated infections
using clinical vignettes and the influence of respondent
characteristics: a cross-sectional survey of Australian infec-
tion prevention staff. Antimicrob Resist Infect Control 2015;
4:29.
[12] Mitchell BG, Gardner A. A model for influences on reliable and
valid health care-associated infection data. Am J Infect Con-
trol 2014;42:190e2.
[13] Australian Bureau of Statistics. Australian demographic sta-
tistics, Jun 2016. 2016. http://www.abs.gov.au/ausstats/
abs@.nsf/mf/3101.0. [Accessed 20 February 2017].
[14] Australian Institute of Health and Welfare. Australian hospital
statistics 2012e13. In: Australian Institute of Health and
Welfare. Canberra: Australian Government; 2014.
[15] Australian Institute of Health and Welfare. Elective surgery
waiting times 2014e15. In: Australian Institute of health and
Welfare. Canberra: Australian Government; 2015.
[16] Australian Institute of Health and Welfare. Admitted patient
care 2014-15. In: Australian Institute of health and Welfare.
Canberra: Australian Government; 2016.
[17] Australian Commission on Safety and Quality in Health Care.
Australian atlas of healthcare variation. Canberra: Australian
Commission on Safety and Quality in Health Care; 2015.
[18] Si D, Runnegar N, Marquess J, Rajmokan M, Playford EG.
Characterising health care-associated bloodstream infections
in public hospitals in Queensland, 2008e2012. Med J Aust
2016;204(7):276.
[19] Mitchell BG, Collignon PJ, McCann R, Wilkinson IJ, Wells A. A
major reduction in hospital-onset Staphylococcus aureus
bacteremia in Australia-12 years of progress: an observational
study. Clin Infect Dis: Off Publ Infect Dis Soc Am 2014;59(7):
969e75.
[20] Alcorn K, Gerrard J, Macbeth D, Steele M. Seasonal variation
in health care-associated bloodstream infection: increase in
the incidence of gram-negative bacteremia in nonhospitalized
128 B.G. Mitchell et al.patients during summer. Am J Infect Control 2013;41(12):
1205e8.
[21] Anderson E, Leahy O, Cheng AC, Grummet J. Risk factors for
infection following prostate biopsy e a case control study.
BMC Infect Dis 2015;15:580.
[22] Aubron C, Suzuki S, Glassford NJ, Garcia-Alvarez M,
Howden BP, Bellomo R. The epidemiology of bacteriuria and
candiduria in critically ill patients. Epidemiol Infect 2015;
143(3):653e62.
[23] Wong SW, Gantner D, McGloughlin S, Leong T, Worth LJ,
Klintworth G, et al. The influence of intensive care unit-
acquired central line-associated bloodstream infection on
in-hospital mortality: a single-center risk-adjusted analysis.
Am J Infect Control 2016;44(5):587e92.
[24] Coombs GW, Nimmo GR, Pearson JC, Collignon PJ, Bell JM,
McLaws ML, et al. Australian group on antimicrobial resistance
hospital-onset Staphylococcus aureus surveillance programme
annual report, 2011. Commun Dis Intell Q Rep 2013;37(3):
E210e8.
[25] Chandrananth J, Rabinovich A, Karahalios A, Guy S, Tran P.
Impact of adherence to local antibiotic prophylaxis guidelines
on infection outcome after total hip or knee arthroplasty. J
Hosp Infect 2016;93(4):423e7.
[26] Tao P, Marshall C, Bucknill A. Surgical site infection in ortho-
paedic surgery: an audit of peri-operative practice at a ter-
tiary centre. Healthc Infect 2015;20(2):39e45.
[27] Worth LJ, Bull AL, Spelman T, Brett J, Richards MJ. Dimin-
ishing surgical site infections in Australia: time trends in
infection rates, pathogens and antimicrobial resistance using
a comprehensive Victorian surveillance program, 2002e2013.
Infect Control Hosp Epidemiol 2015;36(4):409e16.
[28] Roth H, Millar JL, Cheng AC, Byrne A, Evans S, Grummet J. The
state of TRUS biopsy sepsis: readmissions to Victorian hospi-
tals with TRUS biopsy-related infection over 5 years. BJU Int
2015;116(Suppl. 3):49e53.
[29] Brogan E, Langdon C, Brookes K, Budgeon C, Blacker D. Res-
piratory infections in acute stroke: nasogastric tubes and
immobility are stronger predictors than dysphagia. Dysphagia
2014;29(3):340e5 (0179051X).
[30] Macesic N, Kotsimbos TC, Kelly P, Cheng AC. Hospital-acquired
influenza in an Australian sentinel surveillance system. Med J
Aust 2013;198(7):370e2.
[31] Sanagou M, Leder K, Cheng AC, Pilcher D, Reid CM, Wolfe R.
Associations of hospital characteristics with nosocomial
pneumonia after cardiac surgery can impact on standardized
infection rates. Epidemiol Infect 2016;144(5):1065e74.
[32] Foster NF, Collins DA, Ditchburn SL, Duncan CN,
Schalkwyk JW, Golledge CL, et al. Epidemiology of Clos-
tridium difficile infection in two tertiary-care hospitals in
Perth, Western Australia: a cross-sectional study. New Mi-
crobes New Infect 2014;2(3):64e71.
[33] Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L,
Kennedy KJ, et al. Increasing incidence of Clostridium difficile
infection, Australia, 2011e2012. Med J Aust 2014;200(5):272e6.[34] Worth LJ, Spelman T, Bull AL, Brett JA, Richards MJ. Epide-
miology of Clostridium difficile infections in Australia:
enhanced surveillance to evaluate time trends and severity of
illness in Victoria, 2010e2014. J Hosp Infect 2016;93(3):
280e5.
[35] Mitchell BG, Ferguson JK, Anderson M, Sear J, Barnett A.
Length of stay and mortality associated with healthcare-
associated urinary tract infections: a multi-state model. J
Hosp Infect 2016;93(1):92e9.
[36] Zarb P, Coignard B, Griskeviciene J, Muller A,
Vankerckhoven V, Weist K, et al. The European Centre for
Disease Prevention and Control (ECDC) pilot point prevalence
survey of healthcare-associated infections and antimicrobial
use. Euro Surveill 2012;17(46):20316.
[37] Gravel D, Taylor G, Ofner M, Johnston L, Loeb M, Roth V,
et al., The Canadian Nosocomial Infection Surveillance Pro-
gram. Point prevalence survey for healthcare-associated in-
fections within Canadian adult acute-care hospitals. J Hosp
Infect 2007;66(3):243e8.
[38] Australian Institute of Health and Welfare. Staphylococcus
aureus bacteraemia in Australian public hospitals 2015e16:
Australian hospital statistics. Health services series no. 74.
Cat. No. HSE 184. Canberra: Australian Institute of Health and
Welfare; 2017.
[39] Jones CA, Davis JS, Looke DF. Death from an untreatable
infection may signal the start of the post-antibiotic era. Med J
Aust 2017;206(7):292e3.
[40] Australian Medical Association. Australian national centre for
Disease Control (CDC) e 2017. Australian Medical Association;
2017.
[41] Mumford V, Reeve R, Greenfield D, Forde K, Westbrook J,
Braithwaite J. Is accreditation linked to hospital infection
rates? A 4-year, data linkage study of Staphylococcus aureus
rates and accreditation scores in 77 Australian acute hospi-
tals. Int J Qual Health Care: J Int Soc Qual Health Care 2015;
27(6):479e85.
[42] Phan K, Schultz K, Huang C, Halcrow S, Fuller J, McDowell D,
et al. External ventricular drain infections at the Canberra
Hospital: a retrospective study. J Clin Neurosci: Off J Neuro-
surg Soc Australas 2016;32:95e8.
[43] Ezzatzadegan S, Chen S, Chapman JR. Invasive fungal in-
fections after renal transplantation. Int J Organ Transplant
Med 2012;3(1):18e25.
[44] Gautam A, Ganu SS, Tegg OJ, Andresen DN, Wilkins BH,
Schell DN. Ventilator-associated pneumonia in a tertiary
paediatric intensive care unit: a 1-year prospective observa-
tional study. Crit Care Resusc: J Australas Acad Crit Care Med
2012;14(4):283e9.
[45] Mathot F, Duke T, Daley AJ, Butcher T. Bacteremia and
pneumonia in a tertiary PICU: an 11-year study. Pediatr Crit
Care Med: J Soc Crit Care Med World Fed Pediatr Intensive Crit
Care Soc 2015;16(2):104e13.
